{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T08:49:35Z","timestamp":1778057375452,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","issue":"3","content-domain":{"domain":["jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.jocn.2013.07.019","type":"journal-article","created":{"date-parts":[[2013,12,12]],"date-time":"2013-12-12T18:30:30Z","timestamp":1386873030000},"page":"390-394","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["APOE gene polymorphisms and susceptibility to Creutzfeldt\u2013Jakob disease"],"prefix":"10.1016","volume":"21","author":[{"given":"Yunfei","family":"Wei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanyan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenwu","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhanli","family":"Qu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinming","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2013.07.019_b0005","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1054\/jocn.1999.0191","article-title":"Recent advances in the pre-mortem diagnosis of Creutzfeldt-Jakob disease","volume":"7","author":"Collins","year":"2000","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.jocn.2013.07.019_b0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/brain\/96.1.1","article-title":"The clinical characteristics of transmissible Creutzfeldt-Jakob disease","volume":"96","author":"Roos","year":"1973","journal-title":"Brain"},{"key":"10.1016\/j.jocn.2013.07.019_b0015","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/ana.410200507","article-title":"Creutzfeldt-Jakob disease: clinical analysis of a consecutive series of 230 neuropathologically verified cases","volume":"20","author":"Brown","year":"1986","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2013.07.019_b0020","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1212\/01.WNL.0000160117.56690.B2","article-title":"Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada","volume":"64","author":"Ladogana","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2013.07.019_b0025","first-page":"11","article-title":"Human apolipoprotein E isoprotein subclasses are genetically determined","volume":"33","author":"Zannis","year":"1981","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jocn.2013.07.019_b0030","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/BF00569216","article-title":"Genetic control of human apolipoprotein E polymorphism: comparison of one- and two-dimensional techniques of isoprotein analysis","volume":"60","author":"Utermann","year":"1982","journal-title":"Hum Genet"},{"key":"10.1016\/j.jocn.2013.07.019_b0035","doi-asserted-by":"crossref","first-page":"11445","DOI":"10.1523\/JNEUROSCI.1972-08.2008","article-title":"Impact of apolipoprotein E (ApoE) polymorphism on brain ApoE levels","volume":"28","author":"Riddell","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.jocn.2013.07.019_b0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.1996.tb32592.x","article-title":"Epidemiological, clinical, and neuropathological study of apolipoprotein E genotype in Alzheimer\u2019s disease","volume":"802","author":"Hyman","year":"1996","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.jocn.2013.07.019_b0045","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1474-4422(10)70325-2","article-title":"Apolipoprotein E in Alzheimer\u2019s disease and other neurological disorders","volume":"10","author":"Verghese","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jocn.2013.07.019_b0050","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.plipres.2010.09.001","article-title":"Apolipoprotein E: from lipid transport to neurobiology","volume":"50","author":"Hauser","year":"2011","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.jocn.2013.07.019_b0055","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0006-8993(91)91092-F","article-title":"Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer\u2019s disease and kuru plaque amyloid in Creutzfeldt-Jakob disease","volume":"541","author":"Namba","year":"1991","journal-title":"Brain Res"},{"key":"10.1016\/j.jocn.2013.07.019_b0060","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0304-3940(92)90444-C","article-title":"Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid","volume":"135","author":"Wisniewski","year":"1992","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jocn.2013.07.019_b0065","first-page":"361","article-title":"Human transmissible spongiform encephalopathies","volume":"73","year":"1998","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.jocn.2013.07.019_b0070","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1093\/brain\/awp191","article-title":"Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease","volume":"132","author":"Zerr","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.jocn.2013.07.019_b0075","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1212\/WNL.55.6.811","article-title":"Analysis of EEG and CSF 14\u20133-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease","volume":"55","author":"Zerr","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2013.07.019_b0080","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/S0140-6736(95)90118-3","article-title":"Cerebrospinal fluid concentration of neuron-specific enolase in diagnosis of Creutzfeldt-Jakob disease","volume":"345","author":"Zerr","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.jocn.2013.07.019_b0085","first-page":"249","article-title":"Clinical and laboratory diagnosis of Creutzfeldt-Jakob disease","volume":"19","author":"Weber","year":"2000","journal-title":"Clin Neuropathol"},{"key":"10.1016\/j.jocn.2013.07.019_b0090","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/brain\/101.2.333","article-title":"Subacute spongiform encephalopathy (Creutzfeldt-Jakob disease). The nature and progression of spongiform change","volume":"101","author":"Masters","year":"1978","journal-title":"Brain"},{"key":"10.1016\/j.jocn.2013.07.019_b0095","unstructured":"Collaboration RTC. Review Manager (RevMan) 5.1. 4. Copenhagen: The Nordic Cochrane Centre 2011."},{"key":"10.1016\/j.jocn.2013.07.019_b0100","series-title":"Meta-analysis, Decision Analysis, and Cost-Effectiveness Analysis; Methods for Quantitative Synthesis in Medicine","first-page":"246","author":"Petitti","year":"1994"},{"key":"10.1016\/j.jocn.2013.07.019_b0105","unstructured":"Higgins J, Green S. Cochrane handbook for systematic reviews of interventions version 5.1.0. The Cochrane Collaboration; 2011 [updated 2011 March]. Available from: http:\/\/www.cochrane-handbook.org."},{"key":"10.1016\/j.jocn.2013.07.019_b0110","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.jocn.2013.07.019_b0115","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1212\/WNL.51.2.548","article-title":"APOE in non-Alzheimer amyloidoses: transmissible spongiform encephalopathies","volume":"51","author":"Chapman","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2013.07.019_b0120","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/0140-6736(93)91709-U","article-title":"Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer\u2019s disease and in other amyloid-forming diseases","volume":"342","author":"Saunders","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.jocn.2013.07.019_b0125","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0304-3940(95)11353-3","article-title":"Allelic variations in apolipoprotein E and prion protein genotype related to plaque formation and age of onset in sporadic Creutzfeldt\u2013Jakob disease","volume":"187","author":"Pickering-Brown","year":"1995","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jocn.2013.07.019_b0130","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0304-3940(97)00308-X","article-title":"Alpha1 antichymotrypsin signal peptide polymorphism in sporadic Creutzfeldt\u2013Jakob disease","volume":"227","author":"Salvatore","year":"1997","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jocn.2013.07.019_b0135","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0140-6736(95)91196-0","article-title":"Apolipoprotein E in Creutzfeldt\u2013Jakob disease","volume":"345","author":"Zerr","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.jocn.2013.07.019_b0140","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/S0140-6736(94)90691-2","article-title":"The apolipoprotein E alleles as major susceptibility factors for Creutzfeldt\u2013Jakob disease. The French Research Group on Epidemiology of Human Spongiform Encephalopathies","volume":"344","author":"Amouyel","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.jocn.2013.07.019_b0145","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0304-3940(95)11366-5","article-title":"Allelic variation of apolipoprotein E in Japanese sporadic Creutzfeldt\u2013Jakob disease patients","volume":"187","author":"Nakagawa","year":"1995","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jocn.2013.07.019_b0150","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0304-3940(95)12030-8","article-title":"Apolipoprotein E in sporadic and familial Creutzfeldt\u2013Jakob disease","volume":"199","author":"Salvatore","year":"1995","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jocn.2013.07.019_b0155","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1001\/archneur.1996.00550120041014","article-title":"Apolipoprotein E phenotype frequency and cerebrospinal fluid concentration are not associated with Creutzfeldt\u2013Jakob disease","volume":"53","author":"Zerr","year":"1996","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jocn.2013.07.019_b0160","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0167-4943(96)00750-9","article-title":"Apolipoprotein E(epsilon)4 allele, a risk factor for late onset nonfamilial Alzheimer\u2019s disease among Israeli Jews","volume":"24","author":"Friedman","year":"1997","journal-title":"Arch Gerontol Geriatr"},{"key":"10.1016\/j.jocn.2013.07.019_b0165","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0304-3940(01)02264-9","article-title":"Influence of the prion protein and the apolipoprotein E genotype on the Creutzfeldt\u2013Jakob disease phenotype","volume":"313","author":"Van Everbroeck","year":"2001","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jocn.2013.07.019_b0170","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s12031-007-9001-2","article-title":"ApoE distribution and family history in genetic prion diseases in Germany","volume":"34","author":"Krasnianski","year":"2008","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.jocn.2013.07.019_b0175","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.neurobiolaging.2007.07.014","article-title":"Increased frequency of positive family history of dementia in sporadic CJD","volume":"30","author":"Krasnianski","year":"2009","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.jocn.2013.07.019_b0180","doi-asserted-by":"crossref","first-page":"e22090","DOI":"10.1371\/journal.pone.0022090","article-title":"Genetic cross-interaction between APOE and PRNP in sporadic Alzheimer\u2019s and Creutzfeldt\u2013Jakob diseases","volume":"6","author":"Calero","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jocn.2013.07.019_b0185","doi-asserted-by":"crossref","first-page":"717","DOI":"10.3233\/JAD-2010-101527","article-title":"Amyloid-(beta) 1\u201342 levels are modified by apolipoprotein e (epsilon)4 in Creutzfeldt\u2013Jakob disease in a similar manner as in Alzheimer\u2019s disease","volume":"23","author":"Varges","year":"2011","journal-title":"J Alzheimer\u2019s Dis"},{"key":"10.1016\/j.jocn.2013.07.019_b0190","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.tig.2004.06.014","article-title":"Meta-analysis of genetic association studies","volume":"20","author":"Munafo","year":"2004","journal-title":"Trends Genet"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096758681300489X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096758681300489X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,4]],"date-time":"2019-08-04T21:03:17Z","timestamp":1564952597000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096758681300489X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S096758681300489X"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2013.07.019","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"APOE gene polymorphisms and susceptibility to Creutzfeldt\u2013Jakob disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2013.07.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}